Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.82 |
| ▸ | ACLY | P53396 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714887 | 1.00 | THRB (0.82) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| SCHEMBL714707 | 1.00 | THRB (0.82) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| SCHEMBL713583 | 1.00 | THRB (0.82) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| SCHEMBL517575 | 1.00 | THRB (0.82) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| SCHEMBL517814 | 1.00 | THRB (0.82) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| SCHEMBL8563271 | 1.00 | THRB (0.82) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| Fluoride SCHEMBL6261467 | 0.97 | THRB (0.78) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| SCHEMBL11776383 | 0.97 | THRB (0.78) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| Ammonia Solution, Strong SCHEMBL28638201 | 0.97 | THRB (0.78) | THRBACLYALDH1A1L3MBTL1HDAC1 | |
| Ammonia Solution, Strong SCHEMBL28644453 | 0.97 | THRB (0.78) | THRBACLYALDH1A1L3MBTL1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9447314-B2 | Treatment fluids containing a perfluorinated chelating agent and methods for use thereof | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-09-20 | — | — | US | disclosed |
| US-20160237339-A1 | TREATMENT FLUIDS CONTAINING A PERFLUORINATED CHELATING AGENT AND METHODS FOR USE THEREOF | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-08-18 | — | — | US | disclosed |
| WO-2015053753-A1 | TREATMENT FLUIDS CONTAINING A PERFLUORINATED CHELATING AGENT AND METHODS FOR USE THEREOF | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-04-16 | — | — | WO | disclosed |
| EP-1314725-B1 | SULFONIUM SALT COMPOUND | WAKO PURE CHEM IND LTD (JP) | 2008-03-19 | — | — | EP | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
| US-7049464-B2 | Process for producing of an aminoalkylsulfonic acid and a method of salt exchange for a salt thereof | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2006-05-23 | — | — | US | disclosed |
| US-20050261370-A1 | Process for producing of an aminoalkylsulfonic acid and a method of salt exchange for a salt thereof | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2005-11-24 | — | — | US | disclosed |
| US-6924323-B2 | Sulfonium salt compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2005-08-02 | — | — | US | disclosed |
| EP-1548002-A1 | PROCESS FOR PRODUCING AMINOALKYLSULFONIC ACID AND METHOD OF SALT EXCHANGE FOR SALT THEREOF | Wako Pure Chemical Industries, Ltd. (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-20040033434-A1 | Sulfonium salt compound | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2004-02-19 | — | — | US | disclosed |
| EP-1314725-A1 | SULFONIUM SALT COMPOUND | Wako Pure Chemical Industries, Ltd. (JP) | 2003-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196859-A1 | Novel antibacterial agents | ENGASE, PEPD, PGLS | THRB 3424/4885ACLY 644/4885ALDH1A1 1953/4885 |
| US-20050261370-A1 | Process for producing of an aminoalkylsulfonic acid and a method of salt exchange for a salt thereof | ARSA, ADSL, ASS1 | THRB 3200/4885ACLY 1026/4885ALDH1A1 623/4885 |
| US-20040033434-A1 | Sulfonium salt compound | SPIN1, RER1, SPIN2B | THRB 3571/4885ACLY 4664/4885ALDH1A1 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.